bluebird bio, Inc. (BLUE)
NASDAQ: BLUE · IEX Real-Time Price · USD
0.923
-0.052 (-5.35%)
Jul 2, 2024, 4:00 PM EDT - Market closed

bluebird bio Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year
20222021202020192018 2017 - 2011
Revenue
3.63.660054.58
Upgrade
Revenue Growth (YoY)
-1.77%---54.06%
Upgrade
Cost of Revenue
10.0838.86000.89
Upgrade
Gross Profit
-6.48-35.20053.69
Upgrade
Selling, General & Admin
136.91209.97239.95235.84174.13
Upgrade
Research & Development
240.76319.95319.31327.12448.59
Upgrade
Other Operating Expenses
-97.0625.8000
Upgrade
Operating Expenses
280.61555.72559.26562.96622.72
Upgrade
Operating Income
-287.09-590.91-559.26-562.96-569.02
Upgrade
Interest Expense / Income
-1.03-0.88-5.77-17.38-14.62
Upgrade
Other Expense / Income
-19.6229.0964.52244.571.04
Upgrade
Pretax Income
-266.46-819.12-618.01-790.15-555.44
Upgrade
Income Tax
0.120.260.69-0.550.19
Upgrade
Net Income
-266.58-819.38-618.7-789.61-555.63
Upgrade
Shares Outstanding (Basic)
7969625552
Upgrade
Shares Outstanding (Diluted)
7969625552
Upgrade
Shares Change
14.04%10.83%12.66%6.07%19.52%
Upgrade
EPS (Basic)
-3.39-11.89-9.95-14.31-10.68
Upgrade
EPS (Diluted)
-3.39-11.89-9.95-14.31-10.68
Upgrade
Free Cash Flow
-259.16-650.14-499.34-635.41-469.16
Upgrade
Free Cash Flow Per Share
-3.30-9.44-8.03-11.51-9.02
Upgrade
Gross Margin
-180.15%-961.09%--98.38%
Upgrade
Operating Margin
-7981.43%-16136.29%---1042.57%
Upgrade
Profit Margin
-7411.12%-22375.15%---1018.02%
Upgrade
Free Cash Flow Margin
-7204.92%-17753.74%---859.60%
Upgrade
EBITDA
-262.49-800.35-604.42-790.1-552.9
Upgrade
EBITDA Margin
-7297.53%-21855.54%---1013.03%
Upgrade
Depreciation & Amortization
519.6519.3617.4317.16
Upgrade
EBIT
-267.49-820-623.78-807.53-570.06
Upgrade
EBIT Margin
-7436.56%-22392.11%---1044.47%
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).